The invention provides novel polymorphic and pseudopolymorphic crystalline forms
of 5-azacytidine, along with methods for preparing said forms, wherein 5-azacytidine
is represented by the formula:
##STR1##
The invention also includes pharmaceutical compositions comprising said forms.
